Arrowhead Pharma
(ARWR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Sales | 31 | 24 | 0 | 0 | 0 |
| Gross Profit | 31 | 24 | N/A | N/A | N/A |
| Operating Expenses | 4,900 | 4,063 | 2,913 | 1,770 | 1,812 |
| Operating Income | -4,869 | -4,039 | -2,913 | -1,770 | -1,812 |
| Other Income | -715 | 1,352 | -34 | -175 | 724 |
| Pre-tax Income | -5,584 | -2,687 | -2,947 | -1,945 | -1,087 |
| Net Income Continuous | -5,584 | -2,687 | -2,947 | -1,945 | -1,087 |
| Net Income Discontinuous | -1 | 0 | 0 | -69 | 3,787 |
| Minority Interests | -249 | -201 | -170 | -194 | -206 |
| Net Income | $-5,335 | $-2,486 | $-2,777 | $-1,820 | $2,905 |
| EPS Basic Total Ops | -0.50 | -0.25 | -0.39 | -0.25 | 0.40 |
| EPS Basic Continuous Ops | -0.50 | -0.25 | -0.39 | -0.24 | -0.13 |
| EPS Basic Discontinuous Ops | 0.00 | 0.00 | 0.00 | -0.01 | 0.53 |
| EPS Diluted Total Ops | -0.50 | -0.25 | -0.36 | -0.25 | 0.37 |
| EPS Diluted Continuous Ops | -0.50 | -0.25 | -0.41 | -0.24 | -0.11 |
| EPS Diluted Discontinuous Ops | 0.00 | 0.00 | 0.05 | -0.01 | 0.48 |
| EBITDA(a) | $-4,442 | $-3,581 | $-2,843 | $-1,732 | $-1,728 |